We tested the hypothesis that Insulin resistance, rather than high Insulin level, is associated with lipid and lipoprotein changes favoring atherosclerosis Independently of the glucose tolerance status. To this aim, 50 subjects with normal glucose tolerance, 28 subjects with Impaired glucose tolerance, and 54 subjects with nonlnsulln-dependent diabetes (NIDDM) were studied. Subjects wtth low glucose disposal rate (GDR) or a high degree of Insulin resistance as measured by the euglycemlc hyperinsullnemlc damp technique had lower high density lipoprotein (HDL) cholesterol and higher total and very low density lipoprotein (VLDL) triglycerldea than did subjects wtth high GDR (highest GDR fertile). These associations were Independent of fasting insulin level and other confounding factors. In stepwlse multiple linear regression analysis, GDR was the most important single variable associated with HDL cholesterol and VLDL trigh/ceride level Independently of age, obesity, distribution of obesity (waist/hip ratio), 2-hour glucose level, and free fatty acid concentration. 12 Three prospective population studies, the Helsinki Policemen Study, the Paris Prospective Study, and the Busselton Study, have independently shown that high plasma insulin level is associated with an increased risk of coronary heart disease in nondiabetic male subjects.
The mechanisms by which hyperinsulinemia promotes atherosclerosis are, however, unknown. Several studies indicate that high insulin concentration is associated with adverse changes in serum lipid and lipoprotein levels, characterized by elevated total and very low density lipoprotein (VLDL) triglyceride and decreased high density lipoprotein (HDL) cholesterol levels in subjects with normal glucose tolerance (NGT) 7 - 11 and NIDDM. 11 Since fasting insulin level correlates closely with insulinmediated glucose uptake, 12 it is possible that high insulin concentration Is only an indirect indicator of the link between insulin resistance and adverse changes in lipid and lipoprotein levels. Indeed, two recent studies in subjects with NGT have demonstrated that low insulinmediated glucose uptake is associated with lipid and lipoprotein changes favoring atherosclerosis. 1314 Subjects with impaired glucose tolerance (IGT) and NIDDM are more insulin-resistant than are subjects with NGT, 16 and in both there is an increased risk of atherosclerosis. 2 Therefore, if insulin resistance is a general risk factor for atherosclerosis, low insulin-mediated glucose uptake should be associated with adverse lipid and lipoprotein changes irrespective of the glucose tolerance status. To test this hypothesis, we studied lipid and lipoprotein levels and their association with insulin-mediated glucose uptake in a total of 132 subjects with varying degrees of glucose tolerance.
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Organization criteria. 18 Among diabetic subjects, only patients with NIDDM and those treated with diet only or with oral antidiabetic drugs were included. Eight of the diabetic subjects were treated with diet only, one with metformin, 13 with sutfonylureas, and 28 with a combination therapy of metformin and sulfonylureas. The definition of IGT and NGT was based on a 2-hour oral glucose tolerance test according to the Worid Health Organization criteria. 18 All subjects were in good health as judged by medical history, physical examination, and routine blood and urine tests. All patients had normal liver, kidney, and thyroid function, and no subject was receiving drugs for hyperlipidemia. The use of diuretics and beta-blocking agents was more frequent in patients with NIDDM (28% and 57%, respectively, p<0.05) than in subjects with NGT (8% and 18%, respectively) or in subjects with IGT (11% and 36%, respectively).
Study Protocol
The subjects were admitted to the hospital's metabolic ward for 2 to 3 days. During their stay, a weight-maintaining diet (30 kcal/kg/day) was given; the diet contained 50% carbohydrate, 30% fat, and 20% protein. A 2-hour oral glucose tolerance test and euglycemic hyperinsuiinemic clamp studies were performed after a 12-hour fast
The study protocol was approved by the Ethics Committee of the University of Kuopio. Informed consent was obtained from each subject.
Procedures

Oral Glucose Tolerance Test
After an overnight fast, the oral glucose tolerance test was performed with 75 g of glucose. Blood was drawn at 0, 60, and 120 minutes for the measurement of blood glucose and plasma insulin concentrations. The 2-hour area under the glucose and insulin curve was calculated.
Studies of Insulin Action
Insulin action was assessed with the euglycemic clamp technique. 19 At 7:30 A.M. after a 12-hour overnight fast, an intravenous catheter was placed In an antecubital vein for infusion of insulin, 20% glucose, and H) glucose (New England Nuclear, Boston, MA). Another cannula was inserted into a wrist vein surrounded by a heated box (70°C) for blood sampling. After insertion of the catheters, H) glucose was infused as a primed (40 jiCi) constant (0.40 jiCi/min) infusion for 120 minutes before the starting of insulin infusion. A priming dose of insulin (Velosulin Human, Nordisk Insulin, Gentofte, Denmark) was administered during the initial 10 minutes in a logarithmically decreasing manner to acutely raise serum insulin to the desired level, where it was maintained by a continuous insulin infusion of 40 mU/m J! /min. Steady-state insulin concentrations were 98±2, 100±4, and 91 ± 5 mU/l in subjects with NGT, IGT, and NIDDM, respectively (p=NS between the groups). Blood glucose was maintained at 5.5 mmoVl in each subject for 120 minutes by infusing 20% glucose at varying rates according to blood glucose measurements done at 5-minute intervals (mean coefficient of variation of blood glucose <4% in each group).
Before the initiation of glucose infusion in subjects with NIDDM, blood glucose was allowed to fall to 5.5 mmol/l with insulin infusion. During euglycemic hyperinsuiinemic clamp studies, the rates of glucose appearance (Ra) and disappearance (Rd) were quantified from the serum (3-'H) glucose specific activities and calculated from the Steele's equations in their modified derivative form because the tracer exhibits non-steady-state kinetics under these conditions. 20 The isotope dilution technique has been recently criticized for underestimating the rates of Ra and Rd. Although the reasons for this are not completely dear, it is generally recognized that this underestimation is greatest in non-steady-state and at high glucose turnover rates. 21 Since all subjects were studied in steady-state conditions and the mean glucose disposal rate (GDR) was <6 mg/kg/min, the underestimation of Ra is small in such study conditions. The data were calculated for each 20-minute interval. The mean value for the period 60 to 120 minutes was used to calculate the GDR.
UpkJ and Upoproteln Measurements
Serum lipids and lipoproteins were determined from fresh serum samples drawn after a 12-hour overnight fast LJpoprotein fractionation was performed using ultracentrifugabon and selective precipitation with a modification 22 of the method originally described by Havel et al. 23 All spinnings were done at 1 fJC by using a Kontron TGA-65 ultracentrifuge (Kontron International, Switzerland). Serum samples were centrifuged at density (d)=1.006 (105 000 g, for 18 hours), and VLDL triglycerides (d<1.006) were recovered as the top fraction. Total HDL cholesterol was determined directly with dextrane sulphate and magnesium chloride precipitation, which correlates closely with the results obtained by ultracentrifugation. 22 Low density lipoprotein (LDL) cholesterol (d=1.006 to 1.063, including intermediate density lipoprotein) was calculated as a difference between the bottom fractions. On the average, the mean day-to-day variation in HDL cholesterol measurement was 3.3%, and the daily variation was 0.95%. Cholesterol and triglycerides from the whole serum and from lipoprotein fractions were assayed by automated enzymatic methods (Boehringer-Mannheim, FRG).
Analytic Methods
Blood glucose was measured by the glucose oxidase method (Glucose Auto & Stat HGA-1120 analyzer, Daiici, Kyoto, Japan). Serum free fatty acids (FFA) were determined by the enzymatic method of Wako Chemicals GmbH (Newss, FRG). Plasma insulin was determined by a radioimmunoassay (Phadeseph Insulin RIA 100, Pharmacia Diagnostics AB, Uppsala, Sweden). Coefficients of variation within and between insulin assays were 5% and 4%, respectively. The H) glucose specific activity in blood samples was determined after precipitation of proteins with perchloric add. The supernatant was evaporated to dryness, dissolved in water, and counted in aqueous sdntillation fluid, as previously described. 24 INSULIN RESISTANCE AND UPOPROTEINS (Impaired glucose tolerance or noninsulin-dependent diabetes versus normal Analysis of variance (ANOVA) was used in the comparison of more than two groups, and the adjustment for confounding factors was performed with the analysis of covariance (ANCOVA). Student's two-tailed f test for independent samples was used in the comparison of two groups. Correlations were calculated with Pearson correlation coefficients. Multiple stepwise linear regression analyses were performed to investigate the association of different variables with HDL cholesterol and VLDL triglyceride concentrations and with GDR. In all statistical analyses, logarithmic values for total and VLDL triglycerides and 2-hour insulin area were used, including these variables.
Results
As shown in Table 1 , the study groups did not differ with respect to sex, age, weight, body mass index (BMI), or waist/hip ratio. Fasting insulin was similar between the groups, but 2-hour insulin was higher in subjects with IGT and lower in subjects with NIDDM than in subjects with NGT. Patients with NIDDM had lower 2-hour insulin areas in an oral glucose tolerance test and higher levels of FFA than did subjects with NGT. GDR was significantly lower in subjects with IGT (p<0.05) and in subjects with NIDDM (p<0.01) compared with that in subjects with NGT. In each study group, GDR was similar in men and women (NGT: 6.0±0.4 vs. 5.8±0.5 mg/kg/min; IGT: 4.5±0.5 vs. 4.8±0.6 mg/kg/mln; NIDDM: 4.1 ±0.3 vs. 3.6±0.4 mg/kg/min). Therefore, in all the following statistical analyses the results were combined by sex.
GDR correlated inversely with total and VLDL triglycerides and positively with HDL cholesterol when all subjects were included in the analyses (Table 2) . No consistent correlations between GDR and other lipoprotein fractions were observed, and therefore Table 2 reports only correlations with respect to HDL cholesterol and total and VLDL triglycerides. The correlation between GDR and HDL cholesterol was positive in each group, but only in subjects with IGT did it reach the conventional level of statistical significance. Fasting glucose and 2-hour glucose area in an oral glucose tolerance test correlated significantly with total and VLDL triglycerides, and 2-hour glucose area correlated negatively with HDL cholesterol. However, within each study group (NGT, IGT, NIDDM) these correlations were not statistically significant. Fasting insulin and 2-hour insulin area did not correlate significantly with liplds and lipoproteins in any subject, but in subjects with NGT and IGTs, fasting and 2-hour insulin area correlated significantly and inversely with HDL cholesterol. In addition, in subjects with NGT, correlations of total and VLDL triglycerides with 2-hour insulin area, and in subjects with IGT, correlations of total and VLDL triglycerides with fasting insulin level were positive and statistically significant.
To investigate the possibility that the relationship between GDR and liplds and lipoproteins could be curvilinear, we also calculated liptd and lipoprotein concentrations in the tertiles of GDR (Table 3 ) (lowest tertile <3.32 mg/ kg/min, highest tertile >5.43 mg/kg/min). The tertiles were formed on the basis of GDR in the whole series of subjects, and therefore the limits are similar for subjects with NGT, IGT, and NIDDM. Total, LDL, and VLDL cholesterol and HDL triglycerides did not differ between the GDR tertiles in any of the study groups. HDL cholesterol was significantly higher in the highest GDR tertile than in the lowest tertile in subjects with NGT. In subjects with NGT and NIDDM, total and VLDL triglycerides differed between GDR tertiles and were significantly higher in the highest GDR tertile compared with the lowest tertile. In patients with NIDDM, LDL triglycerides were lower in the highest GDR tertile than in the lowest tertile. Table 4 reports unadjusted and adjusted lipid and lipoprotein levels by GDR tertile and includes all study subjects irrespective of the glucose tolerance status. Adjustment was done separately for fasting insulin (A) and for age, BMI, fasting insulin, and 2-hour glucose in an oral glucose tolerance test and FFA (B). These variables were selected as covariates because age, BMI, fasting insulin, 2-hour glucose, and FFA concentrations were higher in subjects in the highest GDR tertile than in subjects in the lowest GDR tertile (data not shown). All analyses were also done after the exclusion of subjects receiving antihypertensive medication (diuretics or beta blocking agents) (C). HDL cholesterol was higher and total and VLDL triglycerides lower in subjects in the highest GDR tertile than In subjects in the lowest GDR tertile, and these differences persisted even after the adjustment for insulin (A) and other related variables (B). The differences in total and VLDL triglycerides persisted even after the exclusion of subjects with anti hypertensive medication (C). All these analyses were also performed separately in obese (BMI£27.0 kg/m 2 ) and nonobese (BMI<27.0 kg/m 2 ) subjects. The results showed that low HDL cholesterol and high total and VLDL triglycerides were associated with low GDR similarly in both obese and nonobese groups (data not shown). The unadjusted means for VLDL cholesterol and HDL triglycerides were lower in subjects with high GDR compared to subjects with low GDR, but the differences between these subjects disappeared after the adjustment for related factors (B).
Stepwise multiple linear regression analyses were performed to assess the independent contributions of age, BMI, waist/hip ratio, and 2-hour glucose level in an oral glucose tolerance test, fasting FFA concentration, GDR, and fasting Insulin to the variation in HDL cholesterol and VLDL triglycerides (Table 5) . GDR was the most important single variable associated positively wtth HDL cholesterol and negatively with VLDL triglycerides and explained 14% and 24%, respectively, of the variation in HDL cholesterol and VLDL triglycerides. Also, 2-hour glucose associated significantly with HDL cholesterol and VLDL triglycerides, and FFA were associated significantly with HDL cholesterol. When these analyses were performed by substituting fasting Insulin with 2-hour insulin or 2-hour insulin area, the results remained essentially unchanged (data not shown).
Analyses similar to those reported in Table 5 were performed to assess the contribution of age, BMI, waist/ hip ratio, 2-hour glucose, FFA, and HDL cholesterol (Model A) or VLDL triglycerides (Model B) to the variation in GDR. In both models, BMI and 2-hour glucose were associated inversely with GDR and explained 34% and 16%, respectively, of the variation in GDR. VLDL triglycerides were strongly and inversely associated with GDR and explained Values are given in mmol/l. *p<0.05, tp<0.01 (middle or high tertile vs. tow fertile). NGT-nomial glucose tolerance, IGT=lmpaired glucose tolerance, NIDDM=noninsulln-dependent diabetes, HDL=hlgh density lipoprotein, LDL-low density lipoprotein, VLDL=very low density lipoprotein.
24% of the variation in GDR. HDL cholesterol and FFA levels were weakly associated with GDR and explained 4% and 2%, respectively, of the variation in GDR.
Discussion
Our study showed that low HDL cholesterol and high total and VLDL triglycerides were associated with insulin resistance measured by the eugtycemic clamp technique in subjects with NGT (as reported in previous studies 1314 ) and also in subjects with abnormal glucose tolerance and similar ages and obesity. Therefore, impaired insulinmediated glucose uptake is related to adverse lipid and lipoprotein changes irrespective of the glucose tolerance status. Values are given In mmol/1. *p<0.05, tp<0.01, *p<0.001 (middle or high tertile vs. low tertile). A=adjusted for fasting Insulin level (ANCOVA). B=adjusted for age, body mass Index, fasting insulin, 2-hr glucose, and fasting free fatty acids (ANCOVA). C=adjusted for age, body mass Index, fasting insulin, 2-hr glucose, and fasting free fatty acids (ANCOVA) in subjects not receiving antihypertenslve medication (glucose disposal rate tertlles: lowest tertJle<4.62 mg/kg/min, highest tertile>6.71 mg/kg/min).
Logarithmic transformations for total and VLDL triglycerides were used in the comparison of tertile groups including these variables.
See legend to Table 3 for explanation of abbreviations.
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http://atvb.ahajournals.org/ Downloaded from GDR was positively correlated with HDL cholesterol and negatively correlated with total and VLDL triglycerides (Table 2) . Analyses based on the comparison of lipid and lipoprotein levels over the GDR tertlles showed that the relationship between GDR and abnormal lipid and lipoprotein levels was linear with respect to total and VLDL triglycerides (Table 3 ). In contrast, low HDL cholesterol seemed to associate with both the lowest and the middle GDR tertjles. These associations were independent of fasting insulin level and other related factors (Table 4) . These results suggest that previously reported correlations between fasting insulin and lipid and lipoprotein concentrations are only indirect indicators of the association between insulin resistance and adverse lipid and lipoprotein changes. Since the adjustment was done also for 2-hour glucose, these findings show that low HDL cholesterol and high total and VLDL triglyceride concentrations are associated with insulin resistance (low GDR) independently of the glucose tolerance status (NGT, IGT, and NIDDM).
At least three mechanisms must be considered to explain the association between Insulin resistance and lipid and lipoprotein abnormalities: 1) Insulin resistance causes adverse changes in lipids and lipoproteins. 2) Abnormalities in lipids and lipoproteins cause an impairment in insulin action.
3) The association of insulin resistance and abnormal lipid and lipoprotein levels is caused by factors that influence both glucose and lipid metabolism.
The first possibility, that insulin resistance is the primary pathogenetic mechanism responsible for abnormalities in lipid and lipoprotein metabolism, is supported particularly by kinetic studies of triglyceride metabolism. Most studies 26 -26 have indicated that insulin resistance and hyperinsulinemia can induce an overproduction of triglyceride-rich VLDL in the liver by increasing the availability of FFA. However, some studies have failed to show any significant correlation between insulin level and VLDL production, 27 and studies 2829 in isolated hepatocytes have even demonstrated an inhibitory effect of insulin on VLDL production. In addition to increased synthesis, VLDL clearance from the circulation can be reduced in subjects with insulin resistance, particularly in NIDDM, and both increased synthesis and decreased removal rate may coexist. 30 Furthermore, hyperglycemia may stimulate VLDL production. 27 Another possible mechanism is reduced adipose tissue lipoprotein lipase activity, which could restrain the removal of triglyceride-rich particles 3132 and lead to altered HDL cholesterol metabolism. In addition to reduced activity of lipoprotein lipase, increased activity of hepatic lipase 33 could contribute to an inverse association of HDL cholesterol and GDR. Our results, based on regression analyses, showed that GDR was inversely associated with VLDL triglyceride and directly with HDL cholesterol concentrations independently of other confounding factors including fasting insulin level (Table 5) . Therefore, our findings are in agreement with the possibility that insulin resistance might induce abnormalities in lipid and lipoprotein levels. Although HDL cholesterol and VLDL triglyceride metabolism are tightly linked, our findings may further indicate that HDL cholesterol and VLDL triglycerides have separate sites of interaction with insulin action.
A second mechanism is that abnormal lipid and lipoprotein concentrations could induce an impairment in insulin action. In vitro and in vivo studies support this notion. In vitro studies 3430 - 36 have shown that high concentrations of VLDL result in an impairment of insulin action, which is in part due to the inhibition of the glucose transport system. 38 On the other hand, a previous study on normoglycemic subjects 13 has reported that all measured indices of insulin action (insulin-mediated glucose uptake and oxidative and nonoxidative glucose metabolism) correlate significantly with the VLDL secretion rate. Other in vivo studies 37 -38 have demonstrated that an acute infusion of intralipid leads to the reduction of insulin-mediated glucose uptake. With respect to the long-term effects of elevated VLDL concentration on glucose metabolism, it is interesting to note that the Framingham Study has shown that a high VLDL level is a risk factor for glucose intolerance. 39 It remains unknown on the basis of in vivo studies whether the impairment in See legend to Table 3 for explanation of abbreviations.
insulin action is mediated through triglycerides or FFA.
Our study demonstrated that a high VLDL triglyceride level was associated strongly with a low GDR independently of possible confounding factors (Table 6 ). Similarly, a low HDL cholesterol concentration and high FFA levels were related to insulin resistance, although these associations were much weaker than those of VLDL triglycerides and GDR. Therefore, it is possible that both VLDL triglyceride and FFA levels can independently influence insulin action. No previous evidence exists to show that low HDL cholesterol could induce an impairment in insulin-mediated glucose uptake. The third mechanism that may explain the association between insulin action and lipids and lipoproteins is the notion that this association is caused by factors that influence both glucose and llpid metabolism. Obesity could be one of the most important factors causing this association, since it may induce insulin resistance, 40 increase VLDL triglyceride production, 4142 and lower HDL cholesterol, 4344 thus indirectly strengthening the association of adverse lipid and lipoprotein changes and Impaired insulin action. However, we found that low HDL cholesterol and high total and VLDL triglycerides were similarly associated with low GDR in both obese (BMI&27.0 kg/m 2 ) and nonobese (BMI<27.0 kg/m 2 ) subjects. Furthermore, in regression analyses, BMI was not significantly associated with HDL cholesterol or VLDL triglycerides independently of other confounding factors (Table 5 ). In our study subjects, obesity was not an Important factor influencing both glucose and lipid metabolism. Our study subjects were equally obese in each glucose tolerance category, and the range of BMI was small. However, this does not exclude the possibility that, in other study subjects with a wider range of BMI, obesity could be an important variable explaining the association between insulin resistance and abnormal lipid and lipoprotein concentrations. In contrast to previous reports which have demonstrated that the abdominal distribution of obesity is correlated with impaired insulin action 45 and abnormal lipid and lipoprotein levels, 4647 we did not find a statistically significant association between the waist/hip ratio and GDR independently of other variables including BMI.
Although the mechanisms explaining the relationship between insulin resistance and lipid and lipoprotein changes remain unclear and could be due to any of the three mechanisms discussed or their combinations, our results have implications in the understanding of an increased risk of atherosclerosis, particularly in NIDDM. An increased frequency of atherosclerotic events has been reported in subjects with IGT, and at the time of diagnosis, the patients with NIDDM have more atherosclerotic complications than do nondiabetic subjects of corresponding ages. 2 Since subjects with IGT and NIDDM are insulinresistant and since low insulin-mediated glucose uptake is associated with unfavorable lipoprotein changes (high VLDL triglyceride and low HDL cholesterol levels) and with elevated blood pressure levels, 48 insulin resistance should be considered as an important potential risk factor for atherosclerosis. Prospective studies, however, are needed to confirm this association.
